- Moneycontrol /
- Market /
- Pharmaceuticals /
- QUARTERLY RESULTS
BSE Live
Feb 17, 16:00Prev. Close
7367.55
Open Price
7409.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 17, 15:53Prev. Close
7367.75
Open Price
7360.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
7225.50 (10)
| Quarterly Results of Sanofi India (in Rs. Cr.) | Sep '19 | Jun '19 | Mar '19 | Dec '18 | Sep '18 | |
| Net Sales/Income from operations | 779.10 | 747.90 | 717.30 | 676.70 | 700.60 | |
| Other Operating Income | -- | -- | -- | 49.70 | 43.20 | |
| Total Income From Operations | 779.10 | 747.90 | 717.30 | 726.40 | 743.80 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 208.80 | 212.00 | 212.70 | 217.40 | 221.20 | |
| Purchase of Traded Goods | 105.10 | 120.70 | 133.00 | 104.60 | 97.30 | |
| Increase/Decrease in Stocks | 24.10 | 8.50 | -37.80 | -9.20 | -9.20 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 117.00 | 114.10 | 103.60 | 103.50 | 104.60 | |
| depreciat | 26.30 | 26.00 | 26.10 | 25.90 | 26.00 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 148.60 | 134.80 | 152.00 | 172.80 | 142.60 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 149.20 | 131.80 | 127.70 | 111.40 | 161.30 | |
| Other Income | 22.90 | 23.40 | 23.00 | 20.10 | 26.20 | |
| P/L Before Int., Excpt. Items & Tax | 172.10 | 155.20 | 150.70 | 131.50 | 187.50 | |
| Interest | -- | -- | -- | 0.70 | -- | |
| P/L Before Exceptional Items & Tax | 172.10 | 155.20 | 150.70 | 130.80 | 187.50 | |
| Exceptional Items | -39.40 | -- | -- | -- | -- | |
| P/L Before Tax | 132.70 | 155.20 | 150.70 | 130.80 | 187.50 | |
| Tax | 6.10 | 57.80 | 57.80 | 51.50 | 68.30 | |
| P/L After Tax from Ordinary Activities | 126.60 | 97.40 | 92.90 | 79.30 | 119.20 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 126.60 | 97.40 | 92.90 | 79.30 | 119.20 | |
| Equity Share Capital | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 54.96 | 42.29 | 40.34 | 34.48 | 51.83 | |
| Diluted EPS | 54.96 | 42.29 | 40.34 | 34.48 | 51.83 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 54.96 | 42.29 | 40.34 | 34.48 | 51.83 | |
| Diluted EPS. | 54.96 | 42.29 | 40.34 | 34.48 | 51.83 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
29.07.2019
Sanofi India Standalone June 2019 Net Sales at Rs 747.90 crore, up 9.41% Y-o-Y
08.05.2019
07.05.2019
07.05.2019
Sanofi India Standalone March 2019 Net Sales at Rs 717.30 crore, up 16.12% Y-o-Y
